- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Personalized Therapy for Breast Cancer Gene Expression :乳腺癌基因表达的个性化治疗
* * * * Patient’s age and tumor size are routinely used as predictors of recurrence in breast cancer When the recurrence score was combined with data pertaining to age and tumor size to predict risk of distant mets…only the recurrence score remained statistically significant Decreased risk with age may be in part related to increased ER expression in older patients’ tumors – this is captured in recurrence score For tumor size -- 1/3 of patients (tumors smaller than 1 cm) had intermediate-risk or high-risk recurrence scores and a 15-20% risk of distant recurrence. The subgroup analysis of age and tumor size should be interpreted cautiously Concordance b/w pathologists on poorly diff tumors was moderate and for the well-diff and moderately diff grades is low Traditional measures of ER and HER2 expression were only weakly predictive of the risk of distant recurrence (this information was encompassed in the RT-PCR assay) They concluded that they did not know whether the genes used correlate with recurrence in this population b/c they predict responsiveness to tamoxifen, b/c they show a relation with the natural history of breast cancer, or both * At 10 years, risk of death: low 2.8%, intermediate 10.7%, high 15.5% * NSABP Protocol B20, “A Clinical Trial to Determine the Worth of Chemotherapy and Tamoxifen Over Tamoxifen Alone in the Management of Patients with Primary Invasive Breast Cancer, Negative Axillary Nodes and Estrogen-Receptor-Positive Tumors,” enrolled 2,363 patients between October 17,1988, and March 5, 1993, who were randomly assigned to tamoxifen versus tamoxifen plus either CMF or MF * Kaplan-Meier plots for distant recurrence comparing treatment with tamoxifen (Tam) alone versus treatment with tamoxifen plus chemotherapy (Tam chemo). (A) All patients; (B) low risk (recurrence score [RS] 18); (C) intermediate risk (RS 18-30); (D) high risk (RS 31). The number of patients at risk and the number of distant recurrences (in parentheses) are provided belo
您可能关注的文档
最近下载
- 数字化转型背景下高职院校教师信息化教学动力研究--以粤东西北地区为例.pdf VIP
- 制造行业精细化工数字化解决方案(167页).pptx VIP
- 人教版道德与法治四年级上册全册课时练习课件.pptx
- 2024辽宁轨道交通职业学院单招考试文化素质数学试题及参考答案详解【最新】.docx VIP
- 2025年汽车悬架行业分析报告及未来五到十年行业发展趋势报告.docx
- 数字化转型背景下高职教育质量提升的实践研究.docx VIP
- 【2025秋】人教版三年级数学上册教学计划(及进度表).docx
- 手足外科一般护理常规新制.docx VIP
- 数字化转型背景下高职院校教师专业发展新路径研究.docx VIP
- 国测小学四年级下册数学试卷.docx VIP
文档评论(0)